• de
  • en
deen

International

Berlin Chemie
  • About us
    • BERLIN-CHEMIE
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • About us
    • BERLIN-CHEMIE
      • Manufacturing & Quality assurance
      • Business Development
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • Home >>
  • Contact >>
  • Purchasing Terms >>
  • Quality Requirements API / EXC >>
  • Data Protection Information Notice for Healthcare Professionals >>
  • Data Protection Information Notice for Patients >>
  • Privacy >>
  • Disclaimer >>
  • Imprint >>
  • Sitemap >>
  • Change cookie settings »

News and Press Releases

Press|News and Press Releases
  • News and Press Releases
  • Media library

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in

Monday, January 30, 2023
Read more

LAST NEWS

Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat

12/21/2018
Read more

Art in a click: MENARINI launches “Pills of Art”

10/25/2018
Read more

BERLIN-CHEMIE consistent with sustainability goals of United Nations

9/27/2018
Read more

MENARINI announces new governance

3/22/2018
Read more

MENARINI hires their 17.000th employee

3/15/2018
Read more

MENARINI increases number of members of the board - for the first time external members in majority

6/29/2017
Read more
FirstPrevious2345NextLast

News archive

Archive

  • Expand/Collapse 2023 (2)
    • 2023, January (2)
  • Expand/Collapse 2022 (5)
    • 2022, October (1)
    • 2022, September (1)
    • 2022, July (1)
    • 2022, May (2)
  • Expand/Collapse 2021 (3)
    • 2021, November (1)
    • 2021, October (1)
    • 2021, April (1)
  • Expand/Collapse 2020 (7)
    • 2020, November (1)
    • 2020, October (1)
    • 2020, July (1)
    • 2020, June (2)
    • 2020, May (1)
    • 2020, January (1)
  • Expand/Collapse 2019 (1)
    • 2019, September (1)
  • Expand/Collapse 2018 (5)
    • 2018, December (1)
    • 2018, October (1)
    • 2018, September (1)
    • 2018, March (2)
  • Expand/Collapse 2017 (4)
    • 2017, June (1)
    • 2017, March (2)
    • 2017, January (1)
  • Expand/Collapse 2016 (6)
    • 2016, December (2)
    • 2016, November (1)
    • 2016, October (1)
    • 2016, May (1)
    • 2016, March (1)

 

Responsibility >>

BERLIN-CHEMIE

International >>

SCROLL TO TOP Berlin Chemie
Berlin Chemie
  • Home
  • Contact
  • Privacy
  • Change cookie settings »
  • Purchasing Terms
  • Quality Requirements API / EXC
  • Imprint
  • Fair Play Menarini
  • Data Protection Information Notice for Healthcare Professionals
  • Data Protection Information Notice for Patients
  • Disclaimer
  • Sitemap

CONTACT
BERLIN-CHEMIE AG - Glienicker Weg 125 - 12489 Berlin - Germany
Tel.: +49 30 6707-0
Directons: » Contact us

© 2023 BERLIN-CHEMIE AG